USPTO serial 78126399
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Steven H. Hartman
NOVARTIS PHARMACEUTICALS CORPORATION564 MORRIS AVESUMMIT, NJ 07901UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations for use in ophthalmology, vitamin preparations, mineral preparations, pharmaceutical preparations for the prevention or treatment of ocular diseases or disorders; pharmaceutical preparations for use in ophthalmology, vitamin preparations, mineral preparations, pharmaceutical preparations for the prevention or treatment of ocular diseases or disorders | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 19, 2003 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Dec 23, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 23, 2002 | PAPER RECEIVED | — | |
| Aug 21, 2002 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 19, 2002 | DOCK | ASSIGNED TO EXAMINER | — |